The feed-forward loop that involves CXCL8 produced by dysplastic granulocytes of the CMML leukemic clone in the repression of residual WT HSC suggests an innovative strategy for the therapeutic management of CMML patients. This evidence concerns the gene CXCL8 and chronic myelomonocytic leukemia.